Mechanism Analysis of Modified Bugan Yangrong Decoction in the Treatment of Meniere's Disease Based on Network Pharmacology and Molecular Docking

Junxia Hua

doi:10.54254/2753-8818/2026.KA34464

Article Information

Received: 24 April 2026

Published: 15 June 2026

DOI: https://doi.org/10.54254/2753-8818/2026.KA34464

Article Type: Research Article

Cite this article

Hua,J. (2026). Mechanism Analysis of Modified Bugan Yangrong Decoction in the Treatment of Meniere's Disease Based on Network Pharmacology and Molecular Docking. Theoretical and Natural Science,158,59-70.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About this Volume

Volume Title: TNS Vol.158

Part of Series: Theoretical and Natural Science

ISSN: 2753-8818 (Print) / 2753-8826 (Online)

Copyright & License

[1]Lopez-Escamez, J. A., Carey, J., Chung, W. H., et al. (2015). Diagnostic criteria for Menière's disease according to the Classification Committee of the Bárány Society. Journal of Vestibular Research, 25(1), 1–7.

[2]Basura, G. J., Adams, M. E., Monfared, A., et al. (2020). Clinical practice guideline: Menière's disease. Otolaryngology–Head and Neck Surgery, 162(2_suppl), S1–S55.

[3]Sun, Y. (1996). Chishui Xuanzhu. Beijing: China Press of Traditional Chinese Medicine.

[4]Xie, J., Gao, S., Li, L., et al. (2019). Research progress and application strategies of network pharmacology in the field of traditional Chinese medicine. Chinese Traditional and Herbal Drugs, 50(10), 2257–2265.

[5]Ru, J., Li, P., Wang, J., et al. (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6, 13.

[6]Li, X., Wang, X., & Liu, B. (2018). Research progress on the neuroprotective and otoprotective effects of quercetin. Chinese Journal of Otology, 16(5), 693–697.

[7]Zhang, X., & Li, L. (2017). Research progress on the pharmacological effects of kaempferol. China Pharmacy, 28(31), 4449–4452.

[8]Xia, N., Chen, G., Liu, M., et al. (2016). Anti-inflammatory effects of luteolin on experimental autoimmune thyroiditis in mice. Experimental and Therapeutic Medicine, 12(6), 4049–4054.

[9]Liu, Y., & Sun, J. (2016). Research progress in the immunology of Menière's disease. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 51(8), 635–638.

[10]Zhang, N., & Li, H. (2014). Research progress on the relationship between vascular endothelial growth factor and endolymphatic hydrops. Journal of Audiology and Speech Pathology, 22(3), 312–315.

[11]Yang, Y., & Liu, B. (2018). Role of the NF-κB signaling pathway in inflammatory injury of the inner ear. International Journal of Otolaryngology-Head and Neck Surgery, 42(4), 205–208.

[12]Wang, X., & Chen, L. (2017). Research progress on the MAPK signaling pathway and inner ear diseases. Chinese Journal of Otology, 15(2), 260–264.

[13]Zheng, W., Wang, H., & Zhang, Q. (2019). Research progress on the role of the PI3K/Akt signaling pathway in nervous system diseases. Chinese Pharmacological Bulletin, 35(7), 896–900.

[14]Zhao, W., & Huang, L. (2019). Research progress on hypoxia-inducible factors and inner ear diseases. Chinese Journal of Otology, 17(6), 937–941.

[15]Wu, J., & Wang, Q. (2017). Research progress on IL-17 in autoimmune inner ear disease. Chinese Journal of Otology, 15(4), 498–502.

[16]Zhang, L., & Liu, J. (2018). Application of molecular docking technology in the screening of active components of traditional Chinese medicine. Chinese Journal of Experimental Traditional Medical Formulae, 24(12), 212–218.